1256359-22-4

Usage

Uses

Used in Organic Synthesis:
1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propan-1-one is used as a building block for the synthesis of pharmaceuticals, agrochemicals, and optoelectronic materials. Its boron-based functional group and aromatic ring provide versatility in chemical reactions, facilitating the creation of a wide range of organic compounds with diverse applications.
Used in Material Science:
In the field of material science, 1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propan-1-one is utilized as an intermediate for developing new materials with specific properties. The presence of the boron-containing group can influence the material's characteristics, such as stability, reactivity, or electronic properties, making it suitable for applications in various industries.
Used in Pharmaceutical Industry:
1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propan-1-one is used as a key intermediate in the synthesis of pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic effects, contributing to advancements in medicine and healthcare.
Used in Agrochemical Industry:
In agrochemicals, 1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propan-1-one serves as a precursor for the production of pesticides, herbicides, and other agricultural chemicals. Its reactivity and functional groups enable the creation of effective compounds that can protect crops and enhance agricultural productivity.
Used in Optoelectronic Industry:
1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propan-1-one is used as a component in the development of optoelectronic materials, such as organic light-emitting diodes (OLEDs) and photovoltaic cells. Its electronic properties and compatibility with other materials make it a promising candidate for improving the performance and efficiency of optoelectronic devices.

Upstream product

• 74-85-1 ethene 
• 180516-87-4 4-carboxyphenylboronic acid pinacol ester 
• 108-86-1 bromobenzene 
• 10342-83-3 4'-Bromopropiophenone 
• 73183-34-3 bis(pinacol)diborane 

Downstream Products

• 1416164-53-8 1-(4-(2-chloro-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)benzyl)phenyl)-propan-1-one O-methyl oxime 
• 1416165-37-1 (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(4-(1-(methoxyimino)-propyl)benzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate 
• 1416165-36-0 (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(4-propionylbenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate 

Relevant academic research and scientific papers

1,2,4-Triazole-Based N-Heterocyclic Carbene Nickel Complexes - Synthesis and Catalytic Application

Four nickel complexes bearing 1,2,4-triazole-based N-heterocyclic carbene backbones and a cyclopentadienyl ligand were prepared from the corresponding 1,2,4-triazolium salts and nickelocene in tetrahydrofuran (THF) under reflux. The obtained complexes were fully characterized, including by X-ray diffraction analysis. They were then used as catalysts (5 mol-%) for the borylation of aryl bromide derivatives with bis(pinacolato)diboron in the presence of Cs2CO3 as the base in THF at 70 C for 20 h to form the corresponding borylated products in moderate yields. Four new nickel complexes bearing 1,2,4-triazole-based N-heterocyclic carbene backbones and a cyclopentadienyl ligand are prepared, fully characterized, and evaluated in the catalytic borylation of aryl bromides with bis(pinacolato)diboron.

Photoredox/nickel-catalyzed hydroacylation of ethylene with aromatic acids

We report a general, practical and scalable hydroacylation reaction of ethylene with aromatic carboxylic acids with the synergistic combination of nickel and photoredox catalysis. Under ambient temperature and pressure, feedstock chemicals such as ethylene can be converted into high-value-added aromatic ketones in moderate to good yields (up to 92%) with reaction time of 2-6 hours.

Delta opiate receptor antagonist, application thereof and medicine composition

The invention discloses a compound with a structure shown as a general formula (I) (the general formula is shown in the description), a pharmaceutical salt, hydrate or metabolite formed through metabolism in any form, application of the compound with the

Mechanofluorochromic properties of 1,8-diphenylanthracene derivatives

Several types of 1,8-diphenylanthracene derivatives were synthesized and their photophysical properties in the solid state were determined. A relatively high fluorescence quantum yield (of = >0.83) was observed for the 1,8-di(4-fluorophenyl)ant

NOVEL SGLT INHIBITORS

The present invention relates to novel compounds of Formula (I), their pharmaceutically acceptable derivatives, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of Formula (I), their pharmaceutically acceptable derivatives, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of Formula (I) and methods of treating or preventing one or more conditions or diseases that may be regulated or normalized via inhibition of Sodium Glucose Cotransporter-2 (SGLT-2).